A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Linear chromosomes face an 'end-replication problem': the lagging strand template is not fully replicated by DNA polymerase, so 50–200 bp of telomeric DNA (TTAGGG repeats in humans) are lost per division. After ~50–70 divisions, telomeres erode to a critical length, triggering DNA damage checkpoints (via the shelterin complex) and senescence. Telomerase, a ribonucleoprotein reverse transcriptase, replenishes telomere length in germ cells, stem cells, and ~85% of cancer cells, enabling unlimited replication.
Measure telomere length across cell passages; study shelterin protein binding to chromosome ends via chromatin immunoprecipitation.
The end-replication problem is not due to 'lost DNA' but is inherent to semi-conservative replication of linear DNA; it is solved by telomerase adding repeats or, in some organisms, by recombination mechanisms.
From your study of DNA replication, you know that DNA polymerase synthesizes new strands in the 5′→3′ direction and requires an RNA primer to begin. On the leading strand, this works seamlessly — the polymerase simply follows the replication fork continuously. But on the lagging strand, synthesis happens in short Okazaki fragments, each requiring its own primer. Here is the problem: when the very last RNA primer at the chromosome's tip is removed, DNA polymerase has no upstream primer to extend from, so a small stretch of the template strand is left unreplicated. This is the end-replication problem, and it means that every round of cell division shortens the chromosome by 50–200 base pairs at each end.
Telomeres are the cell's solution for making this shortening survivable. Rather than losing coding genes, chromosome ends are capped with thousands of repeats of a simple sequence — TTAGGG in humans — that carry no essential genetic information. These repetitive caps act as a disposable buffer: the cell can afford to lose a few hundred base pairs of TTAGGG repeats each division without any functional consequence. In human somatic cells, telomeres start at roughly 10,000–15,000 base pairs and progressively shorten with each division. After approximately 50–70 divisions, the telomeres reach a critical minimum length, and the cell enters replicative senescence — it permanently stops dividing. This counting mechanism is sometimes called the "mitotic clock."
The protection of chromosome ends involves more than just length. A six-protein complex called shelterin binds specifically to telomeric DNA and prevents the cell's DNA repair machinery from mistaking the natural chromosome end for a double-strand break. Without shelterin, the exposed chromosome tip would trigger DNA damage checkpoints, leading to inappropriate repair attempts — end-to-end chromosome fusions, for example — that would be catastrophic for genome integrity. When telomeres shorten past the critical threshold, shelterin can no longer maintain its protective structure, and the exposed end activates the same damage response pathways (p53 and Rb) that respond to broken DNA, halting the cell cycle.
Telomerase is the enzyme that counteracts the end-replication problem. It is a reverse transcriptase — it carries its own RNA template and uses it to add TTAGGG repeats to the 3′ overhang of the chromosome. In humans, telomerase is active in germ cells (ensuring that offspring start life with full-length telomeres), in stem cells (maintaining their proliferative capacity), and notably in about 85% of cancers. Cancer cells reactivate telomerase to bypass the replicative senescence limit, gaining the ability to divide indefinitely — a hallmark of malignancy. This connection between telomere biology and both aging and cancer makes telomerase one of the most intensely studied enzymes in modern biology.